Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cowin Venture Capital, founded 2000 in Shenzhen, is one of China's first professional VC firms. Listed on NEEQ (832793). RMB 30B+ AUM. 564 investments, 76+ exits, 100+ public company exits. Ranked top 10 most active VC in China.
AI, healthcare, consumer, fintech, industrial, new energy, education. Early-stage focus on "hidden champions" in rising sectors.
564 companies. 76+ exits. 100+ public listings. Notable: Biocytogen, Snapmaker, Bama Tea.
To approach Cowin Venture Capital, founders should prepare a clear pitch that highlights their innovation and market potential. Interested parties can submit their pitches through the firm's website at www.cowincapital.com.cn/en.
Cowin Venture Capital has made 20 investments in the last 12 months, with their most recent investment occurring on June 1, 2025. The firm continues to be recognized as one of the top 10 most active VC firms in China.
Cowin Venture Capital invests in Seed, Series A, and Series B stages.
The firm focuses on AI, healthcare, consumer goods, fintech, industrial, energy, and edtech sectors.
Cowin Venture Capital typically invests between $5 million and $50 million.
Cowin Venture Capital primarily invests in China and across Asia.
Founders can pitch Cowin Venture Capital through their website at www.cowincapital.com.cn/en.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.